I heard over the weekend that Procure was filing for bankruptcy. This is from someone knowledgeable of their finances and the industry, but who is not directly involved with Procure. Can anyone confirm?
What was said is that proton therapy is more expensive yet no more effective than tradition forms of cancer therapies, and that insurance companies are increasingly refusing to pay for proton therapy. It has apparently reached a tipping point at Procure.
Bookmarks